ETrade Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,357
Closed -$731K 858
2019
Q3
$731K Sell
7,357
-122
-2% -$11.6K 0.02% 439
2019
Q2
$691K Sell
7,479
-2,047
-21% -$194K 0.02% 456
2019
Q1
$899K Sell
9,526
-2,607
-21% -$228K 0.03% 359
2018
Q4
$778K Buy
12,133
+893
+8% +$65.9K 0.03% 373
2018
Q3
$1.01M Buy
11,240
+4,049
+56% +$358K 0.03% 363
2018
Q2
$571K Sell
7,191
-14,191
-66% -$1.18M 0.02% 497
2018
Q1
$1.91M Sell
21,382
-4,042
-16% -$388K 0.06% 188
2017
Q4
$2.65M Sell
25,424
-3,446
-12% -$389K 0.09% 135
2017
Q3
$4.21M Sell
28,870
-78
-0.3% -$10.6K 0.15% 70
2017
Q2
$3.76M Buy
28,948
+1,631
+6% +$200K 0.15% 75
2017
Q1
$3.4M Buy
27,317
+1,453
+6% +$174K 0.14% 83
2016
Q4
$2.99M Buy
25,864
+1,003
+4% +$112K 0.14% 85
2016
Q3
$2.6M Sell
24,861
-573
-2% -$62K 0.13% 92
2016
Q2
$2.51M Sell
25,434
-210
-0.8% -$21.7K 0.13% 91
2016
Q1
$2.57M Sell
25,644
-942
-4% -$97K 0.15% 73
2015
Q4
$3.18M Buy
26,586
+344
+1% +$39.8K 0.19% 55
2015
Q3
$2.84M Buy
26,242
+599
+2% +$74.3K 0.17% 64
2015
Q2
$2.97M Buy
25,643
+118
+0.5% +$13.5K 0.17% 59
2015
Q1
$2.94M Buy
25,525
+507
+2% +$60.6K 0.17% 59
2014
Q4
$2.8M Buy
25,018
+523
+2% +$55.2K 0.17% 57
2014
Q3
$2.32M Buy
24,495
+79
+0.3% +$7.13K 0.15% 67
2014
Q2
$2.1M Buy
24,416
+2,228
+10% +$169K 0.14% 91
2014
Q1
$1.55M Buy
22,188
+3,758
+20% +$298K 0.11% 128
2013
Q4
$1.56M Buy
18,430
+3,774
+26% +$299K 0.12% 103
2013
Q3
$1.13M Buy
14,656
+2,454
+20% +$172K 0.1% 114
2013
Q2
$714K Buy
+12,202
New +$734K 0.08% 151

Other funds holding CELG

ETrade Capital Management's CELG Position: Q4 2019 in Review

ETrade Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,357 shares — an estimated $731K sold.

ETrade Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.21M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ETrade Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ETrade Capital Management sold 7,357 Celgene Corp shares in Q4 2019, an estimated $731K.
  • ETrade Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ETrade Capital Management's Celgene Corp position peaked at $4.21M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ETrade Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.